Latest Headlines

  1. Abzena And Mabqi Announce Strategic Partnership To Offer Integrated Discovery Through Development Solution 11/6/2025

    This collaboration will integrate Mabqi’s antibody discovery capabilities with Abzena’s development and manufacturing services, offering biopharma customers a more streamlined, end-to-end drug development solution.

  2. Bora Pharmaceuticals Wins Biotech Company Of The Year Award 11/6/2025

    Bora Pharmaceuticals Co., Ltd. (“Bora” or “the Company”, TWSE: 6472), a global leader in pharmaceutical manufacturing, was named this year’s winner of the Biotech Breakthrough Awards’ Overall Biotech Company of the Year award. The honor recognized Bora’s recent growth and its unique ability to provide the hands-on reliability of a dedicated partner with the infrastructure and scale of a global leader.

  3. Simtra BioPharma Solutions Expands Global Manufacturing Footprint To Advance The Future Of Sterile Injectables 10/27/2025

    In the United States at its site in Bloomington, Indiana, Simtra has added a flexible clinical line for prefilled syringes and liquid and lyophilized vials and is building a new production facility that will house three isolator commercial-scale sterile filling lines.

  4. AGC Biologics Partners With Rarity PBC To Advance Life-Saving Gene Therapy For 'Bubble Baby Disease' 10/24/2025

    AGC Biologics announced an agreement with Rarity PBC to provide comprehensive development and GMP manufacturing for Rarity's gene therapy, RDP-101, for Adenosine Deaminase Severe Combined Immunodeficiency Disorder.

  5. Bora Pharmaceuticals Leverages State-Of-The-Art Isolator Production Line To Scale Supply Of Vital Oncology Therapy 10/23/2025

    Bora Pharmaceuticals Co., Ltd., a global leader in pharmaceutical manufacturing, will leverage its Groninger FlexPro 50 Isolator Line for Vials & Pre-filled Syringes to continue to broaden patients’ access to lifesaving treatments and therapies.

  6. BIOCHINA2026 – Fusion Forward: Uniting The Global Biopharma Community In Suzhou 10/20/2025
  7. MilliporeSigma Introduces Comprehensive AAV Express Platform For Streamlined Gene Therapy Production 10/17/2025
  8. Ensera Launches As New Brand Identity For SteriPack 10/14/2025

    New trading name reflects expanded expertise across design, manufacturing, assembly and packing for global pharma and medical device companies.

  9. TORL Biotherapeutics Secures $96M For ADC Drug Development From UCLA Lab 10/7/2025

    TORL BioTherapeutics LLC (TORL), a clinical stage biotechnology company discovering and developing new antibody-based immunotherapies to improve and extend the lives of patients with cancer worldwide, today announced closing of a $96 million Series C financing. Additionally, updated results from the ongoing Phase 1 study of the Company's Claudin 6 (CLDN6) targeted antibody-drug conjugate (ADC) TORL-1-23 in patients with advanced cancer will be presented in poster sessions at the 2025 European Society of Medical Oncology Congress (ESMO 2025) in Berlin, Germany.

  10. RoosterBio And Secretome Therapeutics Announce Successful Completion Of Large Scale Bioreactor Production For Clinical Stage Cell Therapy Candidate STM-01 10/6/2025

    RoosterBio Inc., a leading supplier of human mesenchymal stem/stromal cells (MSCs), highly engineered media, and bioprocess development services, and Secretome Therapeutics, a clinic-stage company developing novel therapies derived from neonatal cardiac progenitor cells (nCPC) today announced completion of commercial scale production of Secretome’s lead nCPC, STM-01.